These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 36208908)

  • 1. Smell deficits in COVID-19 and possible links with Parkinson's disease.
    Emmi A; Sandre M; Porzionato A; Antonini A
    Int Rev Neurobiol; 2022; 165():91-102. PubMed ID: 36208908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential convergence of olfactory dysfunction in Parkinson's disease and COVID-19: The role of neuroinflammation.
    Li H; Qian J; Wang Y; Wang J; Mi X; Qu L; Song N; Xie J
    Ageing Res Rev; 2024 Jun; 97():102288. PubMed ID: 38580172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Intersection of Parkinson's Disease, Viral Infections, and COVID-19.
    Rosen B; Kurtishi A; Vazquez-Jimenez GR; Møller SG
    Mol Neurobiol; 2021 Sep; 58(9):4477-4486. PubMed ID: 34033061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
    Mysiris DS; Vavougios GD; Karamichali E; Papoutsopoulou S; Stavrou VT; Papayianni E; Boutlas S; Mavridis T; Foka P; Zarogiannis SG; Gourgoulianis K; Xiromerisiou G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.
    Rethinavel HS; Ravichandran S; Radhakrishnan RK; Kandasamy M
    J Chem Neuroanat; 2021 Sep; 115():101965. PubMed ID: 33989761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of SARS-CoV-2 on the development of Parkinson's disease: the role of α-synuclein.
    Iravanpour F; Farrokhi MR; Jafarinia M; Oliaee RT
    Hum Cell; 2024 Jan; 37(1):1-8. PubMed ID: 37735344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical approach towards smell loss in Parkinson's disease.
    Haehner A; Hummel T; Reichmann H
    J Parkinsons Dis; 2014; 4(2):189-95. PubMed ID: 24322062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-viral effects of COVID-19 in the olfactory system and their implications.
    Xydakis MS; Albers MW; Holbrook EH; Lyon DM; Shih RY; Frasnelli JA; Pagenstecher A; Kupke A; Enquist LW; Perlman S
    Lancet Neurol; 2021 Sep; 20(9):753-761. PubMed ID: 34339626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Olfaction and respiratory viruses… A relationship revealed by Covid-19].
    Meunier N
    Med Sci (Paris); 2023 Feb; 39(2):119-128. PubMed ID: 36799746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.
    Petit GH; Berkovich E; Hickery M; Kallunki P; Fog K; Fitzer-Attas C; Brundin P
    PLoS One; 2013; 8(4):e60691. PubMed ID: 23573275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.
    Desai M; Oppenheimer J
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):7-12. PubMed ID: 33130145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and olfactory dysfunction: a looming wave of dementia?
    Kay LM
    J Neurophysiol; 2022 Aug; 128(2):436-444. PubMed ID: 35894511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A primer on viral-associated olfactory loss in the era of COVID-19.
    Soler ZM; Patel ZM; Turner JH; Holbrook EH
    Int Forum Allergy Rhinol; 2020 Jul; 10(7):814-820. PubMed ID: 32271490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Loss of smell, a preliminary indicator of COVID-19].
    Waizel-Haiat S; Waizel-Bucay J
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo neurochemical imaging of olfactory dysfunction in Parkinson's disease.
    Bohnen NI; Müller ML
    J Neural Transm (Vienna); 2013 Apr; 120(4):571-6. PubMed ID: 23263541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.
    Kanjanaumporn J; Aeumjaturapat S; Snidvongs K; Seresirikachorn K; Chusakul S
    Asian Pac J Allergy Immunol; 2020 Jun; 38(2):69-77. PubMed ID: 32563234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.
    Lengacher NA; Tomlinson JJ; Jochum AK; Franz J; Hasan Ali O; Flatz L; Jochum W; Penninger J; ; Stadelmann C; Woulfe JM; Schlossmacher MG
    Acta Neuropathol Commun; 2024 May; 12(1):70. PubMed ID: 38698465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral infection and smell loss: The case of COVID-19.
    Glezer I; Bruni-Cardoso A; Schechtman D; Malnic B
    J Neurochem; 2021 May; 157(4):930-943. PubMed ID: 32970861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.
    D'Ascanio L; Pandolfini M; Cingolani C; Latini G; Gradoni P; Capalbo M; Frausini G; Maranzano M; Brenner MJ; Di Stadio A
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):82-86. PubMed ID: 32662745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.